/GNLKQ
GNLKQ Stock - GeneLink, Inc.
Healthcare|BiotechnologyOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
61
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.26
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GNLKQ
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-157.42
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|
| Revenue | $2.14M | $4.68M | $7.84M | $8.56M | $6.38M |
| Gross Profit | $464,683 | $2.95M | $4.98M | $4.91M | $4.56M |
| Gross Margin | 21.8% | 63.0% | 63.5% | 57.3% | 71.6% |
| Operating Income | $-3,468,997 | $-3,566,615 | $-2,402,744 | $-2,462,227 | $-2,233,401 |
| Net Income | $-3,051,747 | $-3,830,196 | $-2,634,724 | $-2,716,753 | $-2,603,509 |
| Net Margin | -142.9% | -81.8% | -33.6% | -31.7% | -40.8% |
| EPS | $-0.01 | $-0.02 | $-0.02 | $-0.03 | $-0.03 |
Company Overview
GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products. The company was founded in 1994 and is based in Orlando, Florida.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GNLKQLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about GNLKQ
What is GNLKQ's current stock price?
GeneLink, Inc. (GNLKQ) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for GNLKQ?
No analyst price targets are currently available for this stock.
What sector is GeneLink, Inc. in?
GeneLink, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is GNLKQ's market cap?
GeneLink, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does GNLKQ pay dividends?
No, GeneLink, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBSSP
Baseline Productions, Inc.
$0.00
Mkt Cap: $0.0B
CNBX
CNBX Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
ENDV
Endonovo Therapeutics, Inc.
$0.00
Mkt Cap: $0.0B
FLHLF
Filament Health Corp.
$0.00
Mkt Cap: $0.0B
GMVDF
G Medical Innovations Holdings Ltd
$0.00
Mkt Cap: $0.0B
ITMC
Itoco Inc.
$0.00
Mkt Cap: $0.0B
MCRT
Microart Inc.
$0.00
Mkt Cap: $0.0B
NNRX
Nutranomics, Inc.
$0.00
Mkt Cap: $0.0B
RGIN
Regenicin, Inc.
$0.00
Mkt Cap: $0.0B
RVLP
RVL Pharmaceuticals plc
$0.03
Mkt Cap: $0.0B
Explore stocks similar to GNLKQ for comparison